Clinical Efficacy, Survival, and Adverse Reaction Evaluation of Immune Checkpoint Inhibitor in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.
Ping ZhangXiaomeng ZhangNa ZhuFeifei ZhuangDongmei ZhouPing WangPublished in: Computational and mathematical methods in medicine (2022)
ICIs associated with chemotherapy is effective when treating GC, which can effectively promote the disease control rate of patients, enhance immune function, reduce the level of tumor markers, and prolong survival time. The safety is controllable, which is worth popularizing in clinical practice. However, more studies and follow-up with higher methodological quality and longer intervention time are needed to further verify it.
Keyphrases
- end stage renal disease
- clinical practice
- ejection fraction
- randomized controlled trial
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- free survival
- neoadjuvant chemotherapy
- emergency department
- radiation therapy
- locally advanced
- patient reported outcomes
- liquid chromatography
- electronic health record